Help us reach our family's $5,000 goal!
Meet Crosby
Crosby was diagnosed with Creatine Transporter Deficiency (CTD) in 2021, and he faces challenges most of us can’t imagine. He navigates life mostly nonverbally, manages epilepsy, and relies on us for nearly every daily task—from getting dressed to brushing his teeth.
Despite it all, Crosby remains the sweetest, silliest, and most resilient boy we know.
Since 2012, ACD has led the fight against creatine deficiencies. With 100% of Holiday Heroes donations being directed to research, your participation in this campaign is crucial in helping ACD continue that fight.
Our dream is a future where Crosby can communicate his thoughts, live free from seizures, and gain the independence he deserves.
Your Holiday Heroes Donation Supports Research
UC Berkeley
1-year research award to accelerate the development of a novel method to deliver a key enzyme directly into cells to enable creatine production in individuals with GAMT deficiency.
Johns Hopkins University
2-year research investment to accelerate their work to deliver creatine to the brain, including to neurons, using dendrimer nanoparticles, without the need of a creatine transporter, to help patients with CTD.
Stanford University
2-year research award to build upon their work developing new ways to deliver creatine directly into cells without relying on the faulty transporter protein that causes CTD.
Ultragenyx
Investment in the clinical development of an investigational therapy for Creatine Transporter Deficiency (CTD) with a total commitment of $4 million as the program progresses.
Research Fellowship
Help us award our 6th year of research fellowships supporting 12 months of CCDS research for young researchers establishing their careers.
CTD Newborn Screening Research
Support assay development for CTD newborn screening technology enabling advocacy for early diagnosis of Creatine Transporter Deficiency.
